{
    "id": "2ac009f2-257f-4603-a1e8-c50aa9e31f4b",
    "indications": "Nitroglycerin sublingual tablets are indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.",
    "contraindications": "Administer one tablet under the tongue or in the buccal pouch at the first sign of an acute anginal attack. Allow tablet to dissolve without swallowing. One additional tablet may be administered every 5 minutes until relief is obtained. No more than three tablets are recommended within a 15-minute period. If the pain persists after a total of 3 tablets in a 15-minute period, or if the pain is different than is typically experienced, seek prompt medical attention.\n                  Nitroglycerin sublingual tablets may be used prophylactically 5 to 10 minutes prior to engaging in activities that might precipitate an acute attack.\n                  For patients with xerostomia, a small sip of water prior to placing the tablet under the tongue may help maintain mucosal hydration and aid dissolution of the tablet. \n                  Administer nitroglycerin sublingual tablets at rest, preferably in the sitting position.",
    "warningsAndPrecautions": "Nitroglycerin Sublingual Tablets are supplied as white, round, flat-faced tablets in 3 strengths (0.3 mg, 0.4 mg, and 0.6 mg) in bottles containing 100 tablets each, with color-coded labels, and in color-coded Patient Convenience Packages of 4 bottles of 25 tablets each.\n                     0.3 mg: Coded “N” on one side and “3” on the other.                 NDC 59762-4921-1—Bottle of 100 tablets\n                     0.4 mg: Coded “N” on one side and “4” on the other.                 NDC 59762-3304-2—Bottle of 25 tablets                 NDC 59762-3304-3—Convenience Package Carton of 4 Bottles of 25 tablets                 NDC 59762-3304-1—Bottle of 100 tablets\n                     0.6 mg: Coded “N” on one side and “6” on the other.                 NDC 59762-0489-1—Bottle of 100 tablets\n                  Store at Controlled Room Temperature 20°–25°C (68°–77°F) [see USP]. Nitroglycerin should be kept in the original glass container and must be tightly capped after each use to prevent loss of tablet potency.",
    "adverseReactions": "• Use of phosphodiesterase type 5 (PDE-5) inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil, or soluble guanylate cyclase (sGC) stimulators. ( 4.1 , 7.1 ) • Severe anemia ( 4.2 ) • Increased intracranial pressure ( 4.3 ) • Hypersensitivity to nitroglycerin or to other nitrates or nitrites or any excipient ( 4.4 ) • Circulatory failure and shock ( 4.5 )",
    "ingredients": [
        {
            "name": "NITROGLYCERIN",
            "code": "G59M7S0WS3"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "GLYCERYL MONOSTEARATE",
            "code": "230OU9XXE4"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CALCIUM STEARATE",
            "code": "776XM7047L"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        }
    ],
    "organization": "Mylan Pharmaceuticals Inc.",
    "name": "NITROGLYCERIN",
    "effectiveTime": "20241015"
}